Research Library

New research finds that health care consolidation and the integration of hospital and doctor services not only fail to improve quality but also reduce patient satisfaction.

By Eugene Lin, Matthew W. Mell, Wolfgang C. Winkelmayer and Kevin F. Erickson U.S. patients without Medicare who develop end-stage kidney disease become Medicare eligible by their fourth dialysis month. This delay in insurance coverage can lead to disparities in health care that may not fully correct over time, write the authors in the Clinical Journal of American Society of Nephrology: https://bit.ly/2SEW20u

The authors examine the relationship between market competition and the use of surgical services for cancer to test the theory that market competition promotes patient access and health care delivery.

Vivian Ho, director of the Center for Health and Biosciences, examines some of the major reasons critics dislike the Affordable Care Act and offers policy recommendations for refining the legislation in the Annual Review of Medicine.

In this study, the authors examine the impact of consolidation among U.S. dialysis providers on: 1) the ability of patients to choose among competing dialysis providers and 2) the market concentration of providers in each hospital service area.

Texans are likely to pay more at freestanding emergency departments than at hospital-based emergency departments or urgent care centers, according to a study co-authored by Vivian Ho, the James A. Baker III Institute Chair in Health Economics and director of the Center for Health and Biosciences.

About 1 million Texans gained health care coverage due to the Affordable Care Act, according to new research by health policy fellows Vivian Ho and Elena Marks. The new findings published in the American Journal of Public Health examined the effects of the ACA’s Marketplace on Texas residents and determined which population subgroups benefited the most and the least.

Insurers and physicians can partner to deliver care more efficiently and save costs, according to a study that examined Cigna’s Collaborative Accountable Care initiative’s partnership with the Medical Clinic of North Texas.

Data on revenues by payer type are used to identify the determinants of rising hospital prices in Texas between 2000 and 2007. By Vivian Ho, Jerome Dugan and Meei-Hsiang Ku-Goto.

Allowing the producer-dominated market to set drug prices has spiraled the cost of cancer drugs out of control. Drug pricing can be reduced while preserving the profit-making incentive, by linking price to a true measure of quality: preservation and meaningful prolongation of life.